Formulations:
- Parenteral > General injections > IV: 50 mg per mL in 5 mL ampoule
Parenteral > General injections > IV: 50 mg per mL in vial
- Local > Topical > Ointment: 5%
Indications:
- Unspecified malignant neoplasms of ill-defined or unspecified sites
- Malignant neoplasms of nasopharynx
- Malignant neoplasm metastasis in large intestine
- Malignant neoplasms of breast
- Malignant neoplasms of rectum
- Malignant neoplasms of colon
- Plantar warts
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Formulations:
- Parenteral > General injections > IV: 50 mg per mL in 5 mL ampoule
Parenteral > General injections > IV: 50 mg per mL in vial
- Local > Topical > Ointment: 5%
Indications:
- Unspecified malignant neoplasms of ill-defined or unspecified sites
- Malignant neoplasms of nasopharynx
- Malignant neoplasm metastasis in large intestine
- Malignant neoplasms of breast
- Malignant neoplasms of rectum
- Malignant neoplasms of colon
- Plantar warts
Source: EML workbook import